Torrent Pharmaceuticals Ltd. — Capital/Financing Update 2021

Nov 11, 2021

f orrenr � PHARffiR

1 J[th ] November, 2021

The Dy. General Manager (Listing Dept.) BSE Lirr ted, Corporate Relationship Dept., 1[st ] Floor, New Trading Ring, P. J. Towers, Dalal Street, Fort, Mumbai - 400 001 (BSE Scrip Code: 500420)

The Manager-Listing Dept., National Stock Exchange of India Ltd., Exch_ange Plaza, 5[th ] Floor, Plot No. C/1, G. Block, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 051 (NSE Scrip Code: TORNTPHARM)

Dear Sir,

Sub.: Intimation of Schedule of Investor Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

With reference to the captioned subject, representatives of the Company are participating in Investors' Meets, as per the below schedule:

Date* 12-Nov-21	Investors meeting Bank of America 2021 India Confrence	Mode Call/Web-meeting
15-Nov-21 &	24thAnnual CITIC CLSA India Forum 2021	Call/Web-meeting
16-Nov-21

* The Schedule is subject to change.

We request you to kindly, take note of the above in pursuance of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Thanking you,

Yours sincerely,

for TORRENT PHARMACEUTICALS LIMITED

==> picture [106 x 28] intentionally omitted <==

MARESH AGRA WAL �[p (LEGAL) & COMPANY SECRETARY]

TORRENT PHARMACEUTICALS LIMITED

CIN : L24230GJ1972PLC002126

Reg.Office: Torrent House, Off Ashram Road, Ahmedabad - 380 009, India. Phone: +91 79 26599000, Fax: +917926582100, www.torrentpharma.com